Global Nivolumab Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Nivolumab Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Nivolumab by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Nivolumab by Country/Region, 2017, 2022 & 2028

2.2 Nivolumab Segment by Type

2.2.1 Injection 4mL

2.2.2 Injection 10mL

2.3 Nivolumab Sales by Type

2.3.1 Global Nivolumab Sales Market Share by Type (2017-2022)

2.3.2 Global Nivolumab Revenue and Market Share by Type (2017-2022)

2.3.3 Global Nivolumab Sale Price by Type (2017-2022)

2.4 Nivolumab Segment by Application

2.4.1 Unresectable Melanoma

2.4.2 Metastatic Melanoma

2.4.3 Metastatic Squamous NSCLC

2.4.4 Classical Hodgkin Lymphoma

2.4.5 Renal Cell Carcinoma

2.4.6 Other

2.5 Nivolumab Sales by Application

2.5.1 Global Nivolumab Sale Market Share by Application (2017-2022)

2.5.2 Global Nivolumab Revenue and Market Share by Application (2017-2022)

2.5.3 Global Nivolumab Sale Price by Application (2017-2022)

3 Global Nivolumab by Company

3.1 Global Nivolumab Breakdown Data by Company

3.1.1 Global Nivolumab Annual Sales by Company (2020-2022)

3.1.2 Global Nivolumab Sales Market Share by Company (2020-2022)

3.2 Global Nivolumab Annual Revenue by Company (2020-2022)

3.2.1 Global Nivolumab Revenue by Company (2020-2022)

3.2.2 Global Nivolumab Revenue Market Share by Company (2020-2022)

3.3 Global Nivolumab Sale Price by Company

3.4 Key Manufacturers Nivolumab Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Nivolumab Product Location Distribution

3.4.2 Players Nivolumab Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Nivolumab by Geographic Region

4.1 World Historic Nivolumab Market Size by Geographic Region (2017-2022)

4.1.1 Global Nivolumab Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Nivolumab Annual Revenue by Geographic Region

4.2 World Historic Nivolumab Market Size by Country/Region (2017-2022)

4.2.1 Global Nivolumab Annual Sales by Country/Region (2017-2022)

4.2.2 Global Nivolumab Annual Revenue by Country/Region

4.3 Americas Nivolumab Sales Growth

4.4 APAC Nivolumab Sales Growth

4.5 Europe Nivolumab Sales Growth

4.6 Middle East & Africa Nivolumab Sales Growth

5 Americas

5.1 Americas Nivolumab Sales by Country

5.1.1 Americas Nivolumab Sales by Country (2017-2022)

5.1.2 Americas Nivolumab Revenue by Country (2017-2022)

5.2 Americas Nivolumab Sales by Type

5.3 Americas Nivolumab Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Nivolumab Sales by Region

6.1.1 APAC Nivolumab Sales by Region (2017-2022)

6.1.2 APAC Nivolumab Revenue by Region (2017-2022)

6.2 APAC Nivolumab Sales by Type

6.3 APAC Nivolumab Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Nivolumab by Country

7.1.1 Europe Nivolumab Sales by Country (2017-2022)

7.1.2 Europe Nivolumab Revenue by Country (2017-2022)

7.2 Europe Nivolumab Sales by Type

7.3 Europe Nivolumab Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Nivolumab by Country

8.1.1 Middle East & Africa Nivolumab Sales by Country (2017-2022)

8.1.2 Middle East & Africa Nivolumab Revenue by Country (2017-2022)

8.2 Middle East & Africa Nivolumab Sales by Type

8.3 Middle East & Africa Nivolumab Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Nivolumab

10.3 Manufacturing Process Analysis of Nivolumab

10.4 Industry Chain Structure of Nivolumab

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Nivolumab Distributors

11.3 Nivolumab Customer

12 World Forecast Review for Nivolumab by Geographic Region

12.1 Global Nivolumab Market Size Forecast by Region

12.1.1 Global Nivolumab Forecast by Region (2023-2028)

12.1.2 Global Nivolumab Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Nivolumab Forecast by Type

12.7 Global Nivolumab Forecast by Application

13 Key Players Analysis

13.1 Ono Pharmaceutical

13.1.1 Ono Pharmaceutical Company Information

13.1.2 Ono Pharmaceutical Nivolumab Product Offered

13.1.3 Ono Pharmaceutical Nivolumab Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Ono Pharmaceutical Main Business Overview

13.1.5 Ono Pharmaceutical Latest Developments

14 Research Findings and Conclusion

Table 1. Nivolumab Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Nivolumab Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Injection 4mL

Table 4. Major Players of Injection 10mL

Table 5. Global Nivolumab Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Nivolumab Sales Market Share by Type (2017-2022)

Table 7. Global Nivolumab Revenue by Type (2017-2022) & ($ million)

Table 8. Global Nivolumab Revenue Market Share by Type (2017-2022)

Table 9. Global Nivolumab Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Nivolumab Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Nivolumab Sales Market Share by Application (2017-2022)

Table 12. Global Nivolumab Revenue by Application (2017-2022)

Table 13. Global Nivolumab Revenue Market Share by Application (2017-2022)

Table 14. Global Nivolumab Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Nivolumab Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Nivolumab Sales Market Share by Company (2020-2022)

Table 17. Global Nivolumab Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Nivolumab Revenue Market Share by Company (2020-2022)

Table 19. Global Nivolumab Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Nivolumab Producing Area Distribution and Sales Area

Table 21. Players Nivolumab Products Offered

Table 22. Nivolumab Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Nivolumab Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Nivolumab Sales Market Share Geographic Region (2017-2022)

Table 27. Global Nivolumab Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Nivolumab Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Nivolumab Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Nivolumab Sales Market Share by Country/Region (2017-2022)

Table 31. Global Nivolumab Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Nivolumab Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Nivolumab Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Nivolumab Sales Market Share by Country (2017-2022)

Table 35. Americas Nivolumab Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Nivolumab Revenue Market Share by Country (2017-2022)

Table 37. Americas Nivolumab Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Nivolumab Sales Market Share by Type (2017-2022)

Table 39. Americas Nivolumab Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Nivolumab Sales Market Share by Application (2017-2022)

Table 41. APAC Nivolumab Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Nivolumab Sales Market Share by Region (2017-2022)

Table 43. APAC Nivolumab Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Nivolumab Revenue Market Share by Region (2017-2022)

Table 45. APAC Nivolumab Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Nivolumab Sales Market Share by Type (2017-2022)

Table 47. APAC Nivolumab Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Nivolumab Sales Market Share by Application (2017-2022)

Table 49. Europe Nivolumab Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Nivolumab Sales Market Share by Country (2017-2022)

Table 51. Europe Nivolumab Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Nivolumab Revenue Market Share by Country (2017-2022)

Table 53. Europe Nivolumab Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Nivolumab Sales Market Share by Type (2017-2022)

Table 55. Europe Nivolumab Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Nivolumab Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Nivolumab Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Nivolumab Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Nivolumab Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Nivolumab Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Nivolumab Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Nivolumab Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Nivolumab Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Nivolumab Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Nivolumab

Table 66. Key Market Challenges & Risks of Nivolumab

Table 67. Key Industry Trends of Nivolumab

Table 68. Nivolumab Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Nivolumab Distributors List

Table 71. Nivolumab Customer List

Table 72. Global Nivolumab Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Nivolumab Sales Market Forecast by Region

Table 74. Global Nivolumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Nivolumab Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Nivolumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Nivolumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Nivolumab Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Nivolumab Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Nivolumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Nivolumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Nivolumab Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Nivolumab Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Nivolumab Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Nivolumab Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Nivolumab Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Nivolumab Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Nivolumab Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Nivolumab Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Nivolumab Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Nivolumab Revenue Market Share Forecast by Application (2023-2028)

Table 92. Ono Pharmaceutical Basic Information, Nivolumab Manufacturing Base, Sales Area and Its Competitors

Table 93. Ono Pharmaceutical Nivolumab Product Offered

Table 94. Ono Pharmaceutical Nivolumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Ono Pharmaceutical Main Business

Table 96. Ono Pharmaceutical Latest Developments

Table 97. Bristol-Myers Squibb Basic Information, Nivolumab Manufacturing Base, Sales Area and Its Competitors

Table 98. Bristol-Myers Squibb Nivolumab Product Offered

Table 99. Bristol-Myers Squibb Nivolumab Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Bristol-Myers Squibb Main Business

Table 101. Bristol-Myers Squibb Latest Developments

List of Figures

Figure 1. Picture of Nivolumab

Figure 2. Nivolumab Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Nivolumab Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Nivolumab Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Nivolumab Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Injection 4mL

Figure 10. Product Picture of Injection 10mL

Figure 11. Global Nivolumab Sales Market Share by Type in 2021

Figure 12. Global Nivolumab Revenue Market Share by Type (2017-2022)

Figure 13. Nivolumab Consumed in Unresectable Melanoma

Figure 14. Global Nivolumab Market: Unresectable Melanoma (2017-2022) & (K Pcs)

Figure 15. Nivolumab Consumed in Metastatic Melanoma

Figure 16. Global Nivolumab Market: Metastatic Melanoma (2017-2022) & (K Pcs)

Figure 17. Nivolumab Consumed in Metastatic Squamous NSCLC

Figure 18. Global Nivolumab Market: Metastatic Squamous NSCLC (2017-2022) & (K Pcs)

Figure 19. Nivolumab Consumed in Classical Hodgkin Lymphoma

Figure 20. Global Nivolumab Market: Classical Hodgkin Lymphoma (2017-2022) & (K Pcs)

Figure 21. Nivolumab Consumed in Renal Cell Carcinoma

Figure 22. Global Nivolumab Market: Renal Cell Carcinoma (2017-2022) & (K Pcs)

Figure 23. Nivolumab Consumed in Other

Figure 24. Global Nivolumab Market: Other (2017-2022) & (K Pcs)

Figure 25. Global Nivolumab Sales Market Share by Application (2017-2022)

Figure 26. Global Nivolumab Revenue Market Share by Application in 2021

Figure 27. Nivolumab Revenue Market by Company in 2021 ($ Million)

Figure 28. Global Nivolumab Revenue Market Share by Company in 2021

Figure 29. Global Nivolumab Sales Market Share by Geographic Region (2017-2022)

Figure 30. Global Nivolumab Revenue Market Share by Geographic Region in 2021

Figure 31. Global Nivolumab Sales Market Share by Region (2017-2022)

Figure 32. Global Nivolumab Revenue Market Share by Country/Region in 2021

Figure 33. Americas Nivolumab Sales 2017-2022 (K Pcs)

Figure 34. Americas Nivolumab Revenue 2017-2022 ($ Millions)

Figure 35. APAC Nivolumab Sales 2017-2022 (K Pcs)

Figure 36. APAC Nivolumab Revenue 2017-2022 ($ Millions)

Figure 37. Europe Nivolumab Sales 2017-2022 (K Pcs)

Figure 38. Europe Nivolumab Revenue 2017-2022 ($ Millions)

Figure 39. Middle East & Africa Nivolumab Sales 2017-2022 (K Pcs)

Figure 40. Middle East & Africa Nivolumab Revenue 2017-2022 ($ Millions)

Figure 41. Americas Nivolumab Sales Market Share by Country in 2021

Figure 42. Americas Nivolumab Revenue Market Share by Country in 2021

Figure 43. United States Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 44. Canada Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 45. Mexico Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 46. Brazil Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 47. APAC Nivolumab Sales Market Share by Region in 2021

Figure 48. APAC Nivolumab Revenue Market Share by Regions in 2021

Figure 49. China Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 50. Japan Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 51. South Korea Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 52. Southeast Asia Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 53. India Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 54. Australia Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 55. Europe Nivolumab Sales Market Share by Country in 2021

Figure 56. Europe Nivolumab Revenue Market Share by Country in 2021

Figure 57. Germany Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 58. France Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 59. UK Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 60. Italy Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 61. Russia Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 62. Middle East & Africa Nivolumab Sales Market Share by Country in 2021

Figure 63. Middle East & Africa Nivolumab Revenue Market Share by Country in 2021

Figure 64. Egypt Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 65. South Africa Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 66. Israel Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 67. Turkey Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 68. GCC Country Nivolumab Revenue Growth 2017-2022 ($ Millions)

Figure 69. Manufacturing Cost Structure Analysis of Nivolumab in 2021

Figure 70. Manufacturing Process Analysis of Nivolumab

Figure 71. Industry Chain Structure of Nivolumab

Figure 72. Channels of Distribution

Figure 73. Distributors Profiles